
SpectraCure Investor Relations Material
Latest events

Q1 2025
28 May, 2025

Q4 2024
20 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SpectraCure
Access all reports
SpectraCure AB is a medical technology company that focuses on developing innovative cancer treatment systems. The company's primary technology involves interstitial photodynamic therapy (PDT), which uses laser light and photo-reactive drugs to treat solid cancer tumors. SpectraCure's proprietary system aims to provide a minimally invasive and highly precise treatment option, particularly for recurrent prostate cancer. The technology is designed to improve the quality of life for patients by targeting and eliminating deep-seated tumors. SpectraCure was founded in 2003 and is headquartered in Lund, Sweden. Its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SPEC
Country
🇸🇪 Sweden